Tanezumab Terminated Phase 3 Trials for Osteoarthritis (OA) Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT01127893Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
NCT00985621Tanezumab In Osteoarthritis Of The Hip Or Knee
NCT00960804Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients
NCT00863772Tanezumab and Nerve Function In Arthritis Patients
NCT00864097Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
NCT00809783Extension Study Of Tanezumab In Osteoarthritis